<div class="section" id="vision">
    <h1>Vision</h1>
    <p>
      NAMetrics is established to advance and promote the research, development, and validation of 
      innovative New Approach Methodologies (NAMs) by fostering collaboration between quantitative 
      and analytical pharmacologists in the pursuit of advancing drug discovery and development.
    </p>
  </div>

  <div class="section" id="team">
    <h1>Team</h1>
    <div class="team-member">
      <p class="name">Krina Mehta, PhD</p>
      <p class="title">Founder</p>
      <img src="Krina_headshot.png" style="max-width: 20%; height: auto; align: left; ">
      <p>
        Krina is a quantitative pharmacologist with over 15 years of experience. Her work specializes in 
        pharmacometrics and translational pharmacology, currently serving as Director at Kyowa Kirin Inc., 
        where she leads strategy and modeling efforts across various therapeutic areas including oncology 
        and rare diseases. Krina has deep expertise in modeling approaches such as PopPK, PBPK, QSP, and 
        semi-mechanistic modeling. She holds a PhD in Quantitative Pharmacology, along with an MS in 
        Pharmacometrics and a BPharm. Her work is reflected in several peer-reviewed publications and 
        conference presentations, and she actively serves on several professional communities, like ISOP 
        and ASCPT. Krina is especially passionate about modernizing drug discovery and development while 
        reducing animal use in pharmacology evaluations.
      </p>
    </div>
  </div>
